Glycostem is developing naked and engineered natural killer (NK) cells, eliminating the logistical complexity and safety concerns associated with existing therapies. NK cells have innate ...

Instead of working with T cells, Glycostem is developing naked and engineered natural killer (NK) cells, eliminating the logistical complexity and safety concerns associated with existing therapies.

Severe infection with Covid-19 has been found to produce a powerful cancer-fighting cell that can shrink tumors.

Clinical relevance: Receptor engineering has significantly advanced NK cell-based cancer immunotherapies. As technical hurdles are overcome, these innovative treatments are poised to revolutionize ...